Clinical Research
Filter News
Found 102,667 articles
-
It’s no secret that China has become an ever-increasing important component for drug development. Not only is the country seen as a lucrative market for drugs, entities within the country are making heavy investments in the global biotech industry.
-
Shares of Ionis Pharmaceuticals are up more than 10 percent in premarket trading after Biogen handed over $1 billion to support a new 10-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases.
-
The U.S. Food and Drug Administration (FDA)’s Peripheral and Central Nervous System Drugs Advisory Committee unanimously recommended the approval of London, UK-based GW Pharmaceuticals’ Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome.
-
Neuropeptide Y Y1 receptor Structures Offer New Opportunities for Anti-obesity Drug Discovery
4/19/2018
-Structures of human neuropeptide Y receptor Y1R reveal drug recognition mechanisms
-
IQVIA™ Institute for Human Data Science Study: U.S. Prescription Opioid Volume Declined 12 Percent in 2017 – Largest Drop in 25 Years
4/19/2018
The latest report from the IQVIA™ Institute for Human Data Science found prescription opioid dosage volume — as defined by Morphine Milligram Equivalents (MME) — declined 12 percent in 2017, marking the largest annual drop in more than 25 years of measurement.
-
World Automated Microbiology Market Report 2018 - ResearchAndMarkets.com
4/19/2018
The "2018 World Automated Microbiology Market" report has been added to ResearchAndMarkets.com's offering.
-
World Tumor Markers Testing Market 2018: Reagents & Instrumentation - Supplier Shares & Strategies, Country Segment Forecasts, Emerging Opportunities - ResearchAndMarkets.com
4/19/2018
The "2018 World Tumor Markers Testing Market: Reagents & Instrumentation - Supplier Shares & Strategies, Country Segment Forecasts, Emerging Opportunities" report has been added to ResearchAndMarkets.com's offering.
-
Acute Pain - 2018 Pipeline Highlights - ResearchAndMarkets.com
4/19/2018
The "Acute Pain Pipeline Highlights - 2018" report has been added to ResearchAndMarkets.com's offering.
-
Acute Myeloid Leukemia Pipeline Highlights 2018 - ResearchAndMarkets.com
4/19/2018
The "Acute Myeloid Leukemia Pipeline Highlights - 2018" report has been added to ResearchAndMarkets.com's offering.
-
It seems inevitable that as marijuana becomes more broadly legal in the U.S., that the biopharma industry and larger corporations will take an interest.
-
Public health officials and scientists have had concerns about how long Ebola vaccines’ protection lasts. A new study shows that one of those vaccines confers at least two years of protection.
-
The 2018 American Association for Cancer Research (AACR) is being held in Chicago. Here’s a roundup of some of today’s company news.
-
Global Neuropathic Back Pain Epidemiology and Patient Flow Analysis 2018 - ResearchAndMarkets.com
4/18/2018
The "Global Neuropathic Back Pain Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
-
Blood Disorders Pipeline Database 2018: Neutropenia, Sickle-cell Disorders, Thalassemia, Iron deficiency anemia, Haemophilia A, and Haemophilia B - ResearchAndMarkets.com
4/18/2018
The "Blood Disorders Pipeline Database - 2018" report has been added to ResearchAndMarkets.com's offering.
-
Rgenix Presents Pre-Clinical Data on RGX-202 at the 2018 AACR Annual Meeting
4/18/2018
Pre-clinical data indicates RGX-202 suppresses cancer growth in colon and pancreatic cancer models Rgenix plans to initiate a clinical study of RGX-202 in patients with advanced gastrointestinal malignancies
-
AcelRx Pharmaceuticals Announces Publication Concluding that Sublingual Sufentanil Tablets Provide the Opportunity to Non-Invasively and Rapidly Treat Moderate-To-Severe Acute Pain in a Monitored Setting
4/18/2018
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, announced the publication of an analysis of the pharmacokinetic characteristics of sublingually administered tablets containing 15 or 30 mcg of sufentanil in a special "Frontiers in Opioid Pharmacotherapy" edition
-
Syngenta Announces a New Malaria Insecticide Entering Early Development Phase
4/18/2018
Syngenta announced today that a new insecticide active ingredient with a novel mode of action to address resistance in the control of malaria vectors is entering the early development phase.
-
Kraig Biocraft Laboratories Releases a Statement Regarding Spider Silk Industry
4/18/2018
As the Company prepares for commercialization of its engineered spider silk, Kraig Labs shares information on the developing industry.
-
MabVax Therapeutics Antibody Program Results Featured in Three Presentations at 2018 American Association for Cancer Research (AACR) Annual Meeting
4/18/2018
Interim results from Phase 1 clinical trial of MVT-1075, demonstrated a dosing strategy for the clinical translation of a radioimmunotherapy product for the treatment of patients with relapsed / refractory pancreatic and other CA19-9 positive cancers
-
Xencor Presents Preclinical Data on XmAb®24306, Introduces XmAb® IL15 Bispecific Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting
4/18/2018
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced preclinical data on XmAb24306, an IL15/IL15-receptor alpha complex fused to a bispecific XmAb Fc domain (IL15/IL15Rα-Fc) for the treatment of multiple oncology indications